Evidence map›Paper›PMID 42246010›Full record

SynthesisFrontiers in cellular and infection microbiology2026

Global prevalence of fluoroquinolone resistance in

Hua Zhou, Tianrui Xue, Jingxin Xue

Abstract readSystematic ReviewMeta-Analysis
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hua ZhouDepartment of Hospital-Acquired Infection Control, Jinan Third People's Hospital, Jinan Third People's Hospital Affiliated with Jining Medical College, Jinan, Shandong, China.
Tianrui XueSchool of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong, China.
Jingxin XueDepartment of Urology Surgery, Jinan Third People's Hospital, Jinan Third People's Hospital Affiliated with Jining Medical College, Jinan, Shandong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Fluoroquinolone resistance in Methods: A systematic review and meta-analysis was conducted in accordance with PRISMA guidelines, including English-language observational studies published through December 2025. PubMed, Embase, and Web of Science were searched for reports on fluoroquinolone-resistant Results: Among 9,033 identified records, 36 studies met the inclusion criteria. The overall pooled prevalence of fluoroquinolone resistance in Conclusion: This analysis demonstrates substantial and geographically heterogeneous fluoroquinolone resistance in

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialEscherichia coliEscherichia coli InfectionsFluoroquinolonesUrinary Tract InfectionsGlobal HealthHumansMicrobial Sensitivity TestsPrevalenceAnti-Bacterial AgentsFluoroquinolonesdrug resistanceEscherichia colifluoroquinolone resistancemeta-analysisurinary tract infections

Identifiers

PMID42246010
PMCPMC13229869

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.